#USA #Vienna #Molecular Diagnostics #Autonomous Medical Devices #Autolab™ HBH

AMDI Revolutionizes Sample Preparation with Autolab™ HBH

At the ESCMID Global Congress in Vienna, Autonomous Medical Devices Incorporated (AMDI) unveiled its latest technological advancement, the Autolab™ HBH system, a tool set to transform sample preparation protocols for molecular diagnostics. This innovative system, grounded in proprietary Hyperbaric Heating (HBH) technology, streamlines the process by rapidly lysing samples and extracting nucleic acids without traditional lengthy methods or the necessity for extraction kits.

A New Era in Molecular Workflows

The release of the Autolab™ HBH signifies a substantial leap forward. Historically, sample preparation in laboratories involved multiple manual steps and considerable amounts of time—typically ranging from 20 to 45 minutes. However, the Autolab HBH dramatically reduces this time to less than 2 minutes. This not only enhances productivity but also offers a cost-effective and high-yield solution that empowers laboratories to transition from sample collection to analysis more efficiently.

David Okrongly, CEO of AMDI, emphasized, "The Autolab™ HBH system was developed to overcome the longstanding challenges in sample preparation—namely complexity, cost, and time. This launch reflects our ongoing mission to deliver advanced tools that improve molecular laboratory workflows overall, ensuring broader access to high-quality molecular testing—from PCR to sequencing."

Versatility Across Various Fields

One of the standout features of the Autolab™ HBH is its versatility in handling various types of sample matrices. This flexibility positions the system to not only cater to diagnostic laboratories but also to find applications in clinical research, public health initiatives, and environmental monitoring. It is worth noting that the Autolab HBH is currently available for research use only (RUO), making it an exciting prospect for academic institutions and laboratories looking to enhance their research capabilities.

Live Demonstrations at ESCMID 2025

As part of its commitment to showcasing the system's capabilities, AMDI hosted live demonstrations at Booth #D760 during the ESCMID 2025 conference. Attendees had the opportunity to witness firsthand the speed and effectiveness of the Autolab™ HBH in action. Feedback from industry professionals has been overwhelmingly positive, with many expressing enthusiasm about the potential impact this technology could have on diagnostic workflows and molecular research.

About AMDI

Autonomous Medical Devices Incorporated, based in California, focuses on creating next-generation solutions aimed at enhancing the speed, access, and accuracy of molecular testing. All AMDI products, including the Autolab™ HBH, are meticulously developed and manufactured in an ISO 13485-certified facility located in Santa Ana, CA. This adherence to high-quality manufacturing standards reaffirms AMDI's commitment to excellence in the medical diagnostics arena.

In conclusion, the launch of the Autolab™ HBH marks a significant progression in molecular diagnostics, showcasing AMDI’s dedication to providing innovative solutions that cater to the evolving needs of laboratories worldwide. As molecular testing continues to expand in scope and importance, tools like the Autolab™ HBH will be critical in shaping the future of diagnostics.